Plain-English translation of NCT07039552 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a tool to predict ovarian cancer risk for people who carry BRCA1 or BRCA2 gene mutations—inherited genes that significantly raise cancer risk. By collecting information about your health, family history, lifestyle, and genes, scientists hope to create a personalized risk calculator that can help guide care decisions for you and your family members.
Many families carry BRCA mutations, but doctors don't yet have a precise way to predict who will develop ovarian cancer and when. This study aims to fill that gap by gathering real-world data from thousands of people, so future patients can get earlier warnings and better-informed treatment plans.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll provide detailed information about your health, family cancer history, lifestyle, and genetic results at enrollment. Then, researchers will call you once a year to check in and ask about any new health changes, particularly whether ovarian cancer has developed. The study expects to enroll 10,000 people across multiple hospitals and will continue following participants over time to see patterns emerge.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China